Polycystic Liver Disease in Kidney Transplant
Learn more about:
Related Clinical Trial
Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts
A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
Open-Label Extension of LOCKCYST Trial
Lanreotide as Treatment of Polycystic Livers
Automatic Segmentation of Polycystic Liver
Octreotide in Severe Polycystic Liver Disease
Pasireotide LAR in Severe Polycystic Liver Disease
Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)
Everolimus and LongActing Octreotide Trial in Polycystic Livers
Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease
Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).
Polycystic Liver Disease in Kidney Transplant
Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease